Abstract:This study presents a simple and energy-efficient self-assembly LAG synthetic method for novel water-soluble copper(I) complexes [Cu(terpy)(PTA)][PF6] (1) and [Cu(terpy)(PTA)2][PF6] (2). They were characterized by FT-IR, 1H, and 31P{1H} NMR spectroscopy, elemental analysis, and single-crystal/powder X-ray diffraction (for 2). The X-ray analysis of compound 2 indicates a bidentate coordination mode of terpyridine to the metal center. Variable-temperature NMR tests indicate dynamic properties for terpyridine in the case of both compounds, as well as for the PTA ligands in the case of 2. Additionally, compounds 1 and 2 exhibit interesting cytotoxic activity, which was tested on normal human dermal fibroblasts (NHDFs), human lung carcinoma (A549), human breast adenocarcinoma (MCF-7), and human cervix carcinoma (HeLa) established cell lines. In comparison to the other tested compounds, complexes 1 and 2 seem to have significantly lower IC50 values against cancer cells (A549, HeLa, MCF-7), indicating their potential as prospective anticancer agents. Moreover, both compounds show no significant toxicity towards normal skin cells (NHDFs), suggesting a certain selectivity in their action on cancer cells. Cisplatin as a reference compound also exhibited considerable cytotoxicity against cancer cells but with a low level of selectivity, which could lead to unwanted effects on normal cells. Remarkably, compounds 1 and 2 exhibit up to 30 times the cytotoxic activity of cisplatin, with a six-fold lower toxicity to normal cells. They also interact strongly with human serum albumin, suggesting potential therapeutic applications. Overall, these compounds hold significant promise as potential chemotherapeutic agents.

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are to design, synthesize and evaluate the effectiveness and selectivity of new water - soluble copper(I) complexes as potential anticancer drugs. Specifically, the researchers synthesized two new water - soluble copper(I) complexes [Cu(terpy)(PTA)][PF₆] (1) and [Cu(terpy)(PTA)₂][PF₆] (2), and characterized them by multiple methods, including FT - IR, ¹H and ³¹P{¹H} NMR spectroscopy, elemental analysis and single - crystal/powder X - ray diffraction. ### Research Background and Objectives 1. **The Severity of Cancer**: - Cancer is a serious disease that causes premature death for many people around the world, and it is expected that cancer cases will increase due to population changes in the next 50 years. - Therefore, it is crucial to keep looking for more effective anticancer drugs. 2. **Research on Copper Complexes**: - Copper plays an important role in many organisms, participating in processes such as cell respiration, iron oxidation, pigment formation, biosynthesis of neurotransmitters and antioxidant defense. - Many copper compounds have been successfully tested as potential anticancer agents, especially copper complexes with terpyridine. 3. **Deficiencies in Existing Research**: - Most of the reported copper - terpyridine complexes are copper(II) complexes, and there are fewer examples of copper(I) complexes. - Known copper(I) complexes usually have lower stability, especially in solution. 4. **Research Objectives**: - Design and synthesize new water - soluble copper(I) complexes that have higher stability and potential anticancer activity. - Evaluate the cytotoxicity of these complexes against normal human dermal fibroblasts (NHDFs), human lung adenocarcinoma cells (A549), human breast adenocarcinoma cells (MCF - 7) and human cervical cancer cells (HeLa). ### Main Findings 1. **Synthesis Methods**: - Two new copper(I) complexes [Cu(terpy)(PTA)][PF₆] (1) and [Cu(terpy)(PTA)₂][PF₆] (2) were synthesized using the liquid - phase - assisted grinding (LAG) technique. - This method is fast, simple and environmentally friendly. 2. **Structural Characterization**: - The complexes were characterized in detail by multiple spectroscopic methods and X - ray diffraction. - Single - crystal X - ray diffraction analysis shows that the terpyridine in compound 2 coordinates to the metal center in a bidentate mode. 3. **Dynamic Properties**: - Variable - temperature NMR tests show that the terpyridine in both compounds exhibits dynamic behavior, and so does the PTA ligand in compound 2. 4. **Cytotoxicity**: - Both complexes show significant cytotoxicity against cancer cells (A549, HeLa, MCF - 7), and their IC₅₀ values are much lower than those of other tested compounds. - Compared with cisplatin, the cytotoxicity of these two complexes is 30 times higher, but their toxicity to normal cells is six times lower, showing a certain selectivity. 5. **Interaction with Human Serum Albumin**: - The strong interaction of the two complexes with human serum albumin indicates that they may have potential for therapeutic applications. ### Conclusions - The new water - soluble copper(I) complexes [Cu(terpy)(PTA)][PF₆] (1) and [Cu(terpy)(PTA)₂][PF₆] (2) have significant anticancer activity and selectivity and are expected to become potential chemotherapeutic drugs.

Design, Synthesis, and Anti-Cancer Evaluation of Novel Water-Soluble Copper(I) Complexes Bearing Terpyridine and PTA Ligands

Synthesis, Characterization, and Cytotoxicity Evaluation of Novel Water‐Soluble Cationic Platinum(II) Organometallic Complexes with Phenanthroline and Imidazolic Ligands

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Synthesis and anticancer activities of novel Pt (II) and Pd (II) complexes with 4‐(2,2′:6′,2′′‐terpyridin‐4′‐yl)phenol as ligand

Copper (II) Complexes Modified with Water-Soluble Porphyrin and Various Small Molecules Ligand for DNA Binding and Potential Selectivity Antitumor Agents

Copper(II) Complexes with 2,2':6',2′′-Terpyridine Derivatives Displaying Dimeric Dichloro-μ-Bridged Crystal Structure: Biological Activities from 2D and 3D Tumor Spheroids to In Vivo Models

The Anti‐Cancer Stem Cell Properties of Copper(II)‐Terpyridine Complexes with Attached Salicylaldehyde Moieties

Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids

DNA interactive and selective anticancer activity studies of copper(II) complexes decorated water‐soluble porphyrin

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Design, Synthesis and Biological Evaluation of a Novel Platinum(ii) Complex Possessing Bioreductive Groups for Cancer Therapy

Novel Water-Soluble Cu(ii) Complexes Based on Acylhydrazone Porphyrin Ligands for DNA Binding and in Vitro Anticancer Activity As Potential Therapeutic Targeting Candidates

Anticancer activity of new water-soluble sulfonated thiosemicarbazone copper(II) complexes targeting disulfide isomerase

Synthesis, characterization and anticancer properties: A series of highly selective palladium(II) substituted-terpyridine complexes

Synthesis and Anti-Cancer Investigations of Copper(II) Complexes Based on Adenine

Copper-assisted anticancer activity of hydroxycinnamic acid terpyridine conjugates on triple-negative breast cancer

Water-soluble copper(II) 5-fluorouracil complexes bearing polypyridyl co-ligands: synthesis, structures and anticancer activity

Antitumor activity of copper(II) complexes with Schiff bases derived from N'-tosylbenzene-1,2-diamine

De novo design and preparation, structural details, and cytotoxic response of a new water soluble (2,2′–bipy)–(phenylalaninato)– μ –chlorido–copper(II) drug candidate against resistant cancer cells

Design, Synthesis, and biological evaluation of copper(II) complexes with phenanthroline-based ligands as potential anticancer agents

Antiproliferative Activity of Platinum(II) and Copper(II) Complexes Containing Novel Biquinoxaline Ligands